DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages

Dermatomyofibroma pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.


Dermatomyofibroma pathology — codes and concepts
open

Introduction

Dermatomyofibroma was first described as a plaque-like dermal fibromatosis. It is a rare but distinct benign dermal proliferation of fibroblasts and myofibroblasts in the dermis.

Histology of dermatomyofibroma

Sections show a subtle, ill-defined, plaque-like dermal proliferation (figure 1). The cells are uniform, slender, spindle-shaped and bland. The cells contain evenly distributed chromatin or vesicular with small nucleoli and indentations is in keeping with a myofibroblastic line of differentiation. Characteristically, the cells are arranged parallel to the epidermis (figures 2, 3).

Dermatomyofibroma pathology

Special studies for dermatomyofibroma

Immunohistochemically, neoplastic cells may express some actin and CD34 positivity. Elastic fibres are increased which can be demonstrated with elastic stains.

Differential diagnosis of dermatomyofibroma pathology

Immunohistochemical studies may be used to exclude other spindle cell lesions. The lack of expression of S-100 excludes neurofibroma and desmoplastic spindle cell naevus. Lack of epithelial membrane antigen expression excludes perineurioma.

See smartphone apps to check your skin.
[Sponsored content]

 

Related information

 

References

  • Mentzel T, Kutzner H. Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm. Am J Dermatopathol. 2009 Feb;31(1):44-9. PubMed.
  • Weedon’s Skin Pathology (Third edition, 2010). David Weedon

On DermNet NZ

Books about skin diseases

See the DermNet NZ bookstore.